A study by CMI/Compas found that most doctors believe in the need to cut back on direct-to-consumer pharmaceutical advertising because it is not strictly regulated, encourages excessive use of the drugs and eventually raises health care costs. Supporters say direct ads boost patient-doctor discussions and teach patients about their options for treatment.

Related Summaries